A Phase 4 interventional study of Montelukast and Education in Asthma, sponsored by American Lung Association Asthma Clinical Research Centers. Completed at 20 sites in United States. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2010-04-30.
Sponsored by American Lung Association Asthma Clinical Research Centers · Phase 4 and Interventional
The purpose of this research study is to investigate the way that educational approaches and presentation of a drug may affect the response to montelukast and placebo (an inactive medication) in subjects with asthma.
This is a study of the effects of education and drug presentation on efficacy of montelukast and placebo in asthma. This trial will answer the following questions: 1) Is there a true placebo response in asthma that is not due to non-specific factors? 2) Can the placebo effect in asthma be augmented by interventions that increase expectancy of benefit? 3) Can interventions that increase expectancy augment the effect of active treatment? 4) Are placebo effects additive or interactive with treatment effects?
3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.
This study's enrollment of 600 is above the median of 83 across 2,752 interventional studies indexed under Asthma.
Browse Asthma studies →American Lung Association Asthma Clinical Research Centers is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Morning peak expiratory flow
Spirometry
Asthma diaries
Asthma questionnaires (Asthma Control Score, Asthma Symptom Utility Index, Asthma Quality of Life)
Generic health quality of life (SF-36)
Shortness of Breath Questionnaire
Adherence monitoring
This study is completed, as verified in Sep 2006. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
American Lung Association Asthma Clinical Research Centers